Infleqtion to become the first publicly listed neutral-atom quantum technology company and will begin trading on the NYSE under ticker symbol “INFQ” on February 17, 2026
Nearly 100% of trust cash retained ahead of closing Over $550 million of gross proceeds to be delivered to Infleqtion Transaction expected...
Membership comes in recognition of Dr. Anderson’s contributions to optical quantum engineering of ultracold atoms
Churchill Capital is a special-purpose acquisition company that is merging with Infleqtion to take it public. The SPAC deal is expected to close by the end of March 2026, and the combined company will...
With more than $20 million in contracted mission funding to date, the Quantum Gravity Gradiometer Pathfinder Mission, Led by NASA’s Jet Propulsion Laboratory in Southern California, Advances U.S. Leadership...
Execution phase advances quantum-enabled approaches designed to improve energy grid efficiency, resilience, and operational scale
Live test between Chicago and Northwest Indiana shows up to 40X improvement over GPS for keeping digital systems synchronized
Backed by Wellcome Leap program funding and selected to advance to final-stage demonstrations, Infleqtion moves forward with quantum-enabled biomarker discovery for precision oncology
Combined Company to Trade on NYSE as “INFQ”
New research allows for faster computation cycles and more robust error correction, accelerating Infleqtion’s path toward industrial-scale neutral-atom quantum computers